We’ve heard a lot about artificial intelligence (AI) and its importance in the areas of research and development and overall drug discovery. But what impact could AI have on helping retain research study participants and ensure they follow the protocol?
This Clinical Trials Arena article, AI in clinical trial adherence and retention: is it a Pandora’s box? considers that question, with a focus on the use of AI to:
- Develop health-related patient monitoring solutions to identify patient drug-avoidance behaviors
- Provide feedback to help study participants maintain their interest in and desire to continue with the study
- Sift through unstructured data collected by wearable devices to begin recognizing patient disease patterns